Live feed
Filing
SC 13D/A
SC 13D/A0001144204-18-058764·BioLexis Pte Ltd.
Schedule 13D ownership disclosure
Oncobiologics, Inc.
Security class unavailable · CUSIP: 68235M105
Event date: 2018-11-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 99,296,382
- Percent of class
- 78.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-058764
- Form type
- SC 13D/A
- Filer
- BioLexis Pte Ltd.
- CIK
- CIK 1716335
- Filed
- Nov 09, 2018
- Reporting period
- Nov 07, 2018
- Description
- Schedule 13D beneficial ownership